Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Eur Heart J Cardiovasc Imaging ; 23(4): 543-550, 2022 03 22.
Article in English | MEDLINE | ID: mdl-33824984

ABSTRACT

AIMS: We aimed to study the progression of cardiac dysfunction in patients with lamin A/C mutations and explore markers of adverse cardiac outcome. METHODS AND RESULTS: We followed consecutive lamin A/C genotype-positive patients divided into tertiles according to age. Patients underwent repeated clinical examinations, electrocardiograms (ECGs), and echocardiograms. We followed left ventricular (LV) and right ventricular (RV) size and function, and the severity atrioventricular-valve regurgitations. Outcome was death, LVAD implant, or cardiac transplantation. We included 101 patients [age 44 (29-54) years, 39% probands, 50% female]. We analysed 576 echocardiograms and 258 ECGs during a follow-up of 4.9 (interquartile range 2.5-8.2) years. The PR-interval increased at young age from 204 ± 73 to 212 ± 69 ms (P < 0.001), LV ejection fraction (LVEF) declined from middle age from 50 ± 12% to 47 ± 13% (P < 0.001), while LV volumes remained unchanged. RV function and tricuspid regurgitation worsened from middle age with accelerating rates. Progression of RV dysfunction [odds ratio (OR) 1.3, 95% confidence interval (CI) (1.03-1.65), P = 0.03] and tricuspid regurgitation [OR 4.9, 95% CI (1.64-14.9), P = 0.004] were associated with outcome when adjusted for age, sex, comorbidities, LVEF, and New York Heart Association functional class. CONCLUSION: In patients with lamin A/C genotype, electrical disease started at young age. From middle age, LV function deteriorated progressively, while LV size remained unchanged. Worsening of RV function and tricuspid regurgitation accelerated in older age and were associated with outcome. Our systematic map on cardiac deterioration may help optimal monitoring and prognostication in lamin A/C disease.


Subject(s)
Tricuspid Valve Insufficiency , Adult , Echocardiography , Female , Humans , Lamin Type A/genetics , Male , Middle Aged , Mutation , Stroke Volume , Tricuspid Valve Insufficiency/complications , Tricuspid Valve Insufficiency/diagnostic imaging , Tricuspid Valve Insufficiency/genetics , Ventricular Function, Left , Ventricular Function, Right
2.
World J Gastroenterol ; 19(4): 594-6, 2013 Jan 28.
Article in English | MEDLINE | ID: mdl-23382643

ABSTRACT

Esophageo-tracheal fistula is a rare condition, and in most cases such fistulas are caused by malignant disease or emergency endotracheal intubation. A case where a wrapped tablet produced a fistula between the esophagus and trachea is described. The patient is a male born in 1938 who swallowed a tablet without unwrapping it. The patient was treated with self-expanding metal stents (SEMS), but closure of the fistula was not achieved. Different examinations and treatment options are discussed. Surgical treatment for this condition has demonstrated considerable mortality and morbidity. In some cases closure of the fistula can be achieved by use of SEMS. Although we advise treatment of such cases with SEMS, in some cases treatment with stents will prove troublesome and the risk/benefit analysis will have to be reevaluated.


Subject(s)
Drug Packaging , Esophageal Fistula , Esophagoscopy/instrumentation , Foreign Bodies , Iatrogenic Disease , Respiratory Tract Fistula , Stents , Tracheal Diseases , Aged , Bronchoscopy , Deglutition , Esophageal Fistula/diagnosis , Esophageal Fistula/etiology , Esophageal Fistula/therapy , Humans , Male , Predictive Value of Tests , Respiratory Tract Fistula/diagnosis , Respiratory Tract Fistula/etiology , Respiratory Tract Fistula/therapy , Tomography, X-Ray Computed , Tracheal Diseases/diagnosis , Tracheal Diseases/etiology , Tracheal Diseases/therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL